Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 41.05M | 91.14M | 116.74M | 211.81M | 140.67M | 143.99M | 90.06M | 76.97M | 119.87M | 108.03M | 79M | 97.81M | 89.54M | 149.95M | 42.92M | 50.45M | 32.43M |
Short-Term Investments | 18.51M | 60.47M | 69.35M | 2.98M | 2.98M | 2.95M | 71.67M | 127.74M | 45.69M | 96.57M | 120.67M | 160.28M | 214.68M | 219.63M | 197.2M | 234.92M | 285.51M |
Long-Term Investments | n/a | n/a | n/a | n/a | 2.86M | 3.03M | n/a | n/a | 1.58M | 1.57M | 1.71M | 1.71M | 1.72M | 1.72M | 1.72M | 4.63M | 4.6M |
Other Long-Term Assets | 2.33M | 2.7M | 3.65M | 2.87M | 2.86M | 3.03M | 3.01M | 3.23M | 1.58M | 1.57M | 1.71M | 1.71M | 1.72M | 1.72M | 1.72M | 4.63M | 4.6M |
Receivables | 4.38M | 15.98M | 38.61M | 23.77M | 28.89M | 46.92M | 42.69M | 40.92M | 1.72M | 38.09M | 53.53M | 49.42M | 42.89M | 752K | 45.09M | 39.91M | 31.14M |
Inventory | 11.76M | 7.32M | 1.87M | n/a | n/a | 1.33M | n/a | n/a | 1.31M | 1.28M | 8.05M | 1.33M | 10.08M | 746K | 1.28M | 1.59M | 1.58M |
Other Current Assets | 27.29M | 3.23M | 3.47M | 4.57M | 4.5M | 3.74M | 2.97M | 3.1M | 45.17M | 3.21M | 2.88M | 3.2M | 2.28M | 45.13M | 3.99M | 1.31M | 2.94M |
Total Current Assets | 103M | 188.17M | 244.21M | 253.77M | 186.9M | 207.55M | 219.37M | 261.77M | 213.75M | 255.37M | 264.14M | 321.17M | 359.46M | 415.46M | 300.45M | 337.34M | 359.29M |
Property-Plant & Equipment | 48.94M | 51.22M | 65.29M | 64.07M | 67.72M | 71.71M | 73.87M | 77.52M | 72.31M | 71.53M | 65.78M | 64.78M | 57.83M | 51.37M | 50.17M | 46.44M | 46.06M |
Goodwill & Intangibles | 3.81M | 3.88M | 4.28M | 996K | 524K | 330K | 384K | 463K | 443K | 442K | 568K | 612K | 788K | 1M | 1.19M | 1.38M | 1.62M |
Total Long-Term Assets | 55.07M | 57.79M | 73.22M | 67.93M | 71.11M | 75.06M | 77.27M | 81.21M | 74.33M | 73.55M | 68.06M | 67.11M | 60.34M | 54.09M | 53.08M | 52.45M | 52.29M |
Total Assets | 158.07M | 245.96M | 317.44M | 321.7M | 258.01M | 282.62M | 296.64M | 342.98M | 288.08M | 328.92M | 332.2M | 388.27M | 419.8M | 469.55M | 353.53M | 389.79M | 411.58M |
Account Payables | 5.7M | 8.69M | 9.07M | 7.51M | 6.59M | 8.13M | 13.92M | 14.71M | 5.19M | 4.75M | 6.91M | 15.99M | 7.02M | 8.11M | 4.78M | 6.98M | 4.12M |
Deferred Revenue | 12.44M | 12.3M | 18.71M | 38.42M | 31.52M | 28.97M | 29.31M | 31.42M | 22.3M | 23.52M | 20.62M | 22.47M | 24.77M | 22.2M | 6.1M | 4.91M | 2.08M |
Short-Term Debt | 4.63M | n/a | n/a | 5.29M | n/a | n/a | n/a | n/a | n/a | n/a | 2.47M | 2.56M | n/a | 2.32M | 2.27M | 2.92M | n/a |
Other Current Liabilities | 28.3M | 25.3M | 20.23M | 15.92M | 16.8M | 10.29M | 10.7M | 15.22M | 28.52M | 12.67M | 23.25M | 22.02M | 25.67M | 15.83M | 15.5M | 15.21M | 16.43M |
Total Current Liabilities | 51.07M | 64.53M | 63.46M | 82.07M | 66.41M | 72.79M | 75.15M | 76.13M | 63.63M | 64.5M | 66.08M | 73.63M | 66.15M | 62.54M | 41.14M | 41.42M | 31.31M |
Long-Term Debt | 18.67M | 50.24M | 49.87M | 24.95M | n/a | n/a | n/a | n/a | 19.99M | n/a | 19.93M | 21.64M | 23.22M | 23.15M | 23.7M | 19.72M | 19.9M |
Other Long-Term Liabilities | 125.76M | 4.27M | 103.67M | 1.44M | 1.42M | 1.4M | 1.36M | 1.36M | -18.66M | 1.3M | -19.3M | -20.99M | -22.55M | -22.48M | -23.04M | -19.06M | -19.24M |
Total Long-Term Liabilities | 144.43M | 169.59M | 173.99M | 143.35M | 167.22M | 170.31M | 133.36M | 140.21M | 140.57M | 182.54M | 152.78M | 172.72M | 190.5M | 201.04M | 71.41M | 70.44M | 71.12M |
Total Liabilities | 195.5M | 234.11M | 237.45M | 225.43M | 233.63M | 243.1M | 208.51M | 216.33M | 204.21M | 247.04M | 218.87M | 246.35M | 256.65M | 263.58M | 112.55M | 111.85M | 102.42M |
Total Debt | 23.3M | 74.21M | 74.5M | 47.35M | 23.69M | 25.23M | 25.6M | 26.34M | 22.83M | 23.08M | 22.4M | 24.19M | 25.95M | 25.47M | 25.97M | 22.64M | 22.74M |
Common Stock | 2.1M | 2.08M | 2.08M | 2.08M | 2.08M | 1.86M | 1.86M | 1.85M | 1.41M | 1.4M | 1.39M | 1.39M | 1.34M | 1.34M | 1.34M | 1.34M | 1.33M |
Retained Earnings | -1.14B | -1.09B | -1.02B | -1B | -1.07B | -1.02B | -975.26M | -929.65M | -908.27M | -909.3M | -880.05M | -838.63M | -794.11M | -743.85M | -704.99M | -662.59M | -623.52M |
Comprehensive Income | -4.41M | -1.9M | -5.14M | -3.41M | -2.72M | -3.75M | 102K | -3.09M | -1.78M | -875K | 6.68M | -1.04M | -9.31M | -11.14M | -10.1M | -10.38M | -10.22M |
Shareholders Equity | -37.43M | 11.85M | 79.99M | 96.27M | 24.38M | 39.51M | 88.13M | 126.65M | 83.88M | 81.88M | 113.34M | 141.92M | 163.15M | 205.96M | 240.98M | 277.94M | 309.16M |
Total Investments | n/a | 60.47M | 69.35M | 2.98M | 5.84M | 5.97M | 71.67M | 127.74M | 45.69M | 96.57M | 120.67M | 160.28M | 214.68M | 219.63M | 197.2M | 234.92M | 285.51M |